Cardinal Health, Inc. (NYSE:CAH – Get Free Report) has received a consensus rating of “Moderate Buy” from the fourteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $139.36.
Several equities analysts have recently weighed in on the company. Jefferies Financial Group raised Cardinal Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. Wells Fargo & Company boosted their price target on Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. Mizuho began coverage on Cardinal Health in a research report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price target on the stock. Morgan Stanley boosted their price target on Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a research report on Friday, January 31st. Finally, JPMorgan Chase & Co. boosted their price target on Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th.
View Our Latest Research Report on Cardinal Health
Institutional Investors Weigh In On Cardinal Health
Cardinal Health Price Performance
NYSE CAH opened at $132.09 on Thursday. The firm has a market capitalization of $31.91 billion, a P/E ratio of 24.64, a P/E/G ratio of 1.49 and a beta of 0.66. Cardinal Health has a 1-year low of $93.17 and a 1-year high of $132.84. The business’s 50-day simple moving average is $126.94 and its 200-day simple moving average is $119.78.
Cardinal Health (NYSE:CAH – Get Free Report) last released its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, equities research analysts expect that Cardinal Health will post 7.95 EPS for the current fiscal year.
Cardinal Health Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.53%. Cardinal Health’s dividend payout ratio is presently 37.69%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More
- Five stocks we like better than Cardinal Health
- How to Invest in Blue Chip Stocks
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- What is a Stock Market Index and How Do You Use Them?
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.